Clinical Trials Browser

Jacobs syndrome × Cyclophosphamide × Plasma cell × Clear all

NCT02572596 2017-02-09

Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients

Phase NA Unknown

Jacobs syndrome, Multiple Myeloma